Evaluating Targeted Therapeutic Response With Predictive Blood-Based Biomarkers in Patients With Chronic Mild Traumatic Brain Injury

Chronic consequences of mild traumatic brain injury (mTBI) are heterogeneous, but may be treatable with targeted medical and rehabilitation interventions. A biological signature for the likelihood of response to therapy (i.e., “predictive” biomarkers) would empower personalized medicine post-mTBI. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Eagle, Shawn R., Puccio, Ava M., Agoston, Denes V., Soose, Ryan, Mancinelli, Michael, Nwafo, Rachel, McIntyre, Peyton, Agnone, Allison, Tollefson, Savannah, Collins, Michael, Kontos, Anthony P., Schneider, Walter, Okonkwo, David O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288300/
https://www.ncbi.nlm.nih.gov/pubmed/37360545
http://dx.doi.org/10.1089/neur.2023.0003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288300/
https://www.ncbi.nlm.nih.gov/pubmed/37360545
http://dx.doi.org/10.1089/neur.2023.0003

Ejemplares similares